Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thermodynamic Analysis of OAB Treatments
NCT07025642Recruiting
- Sponsor
- Mackay Medical College
- Start
- Jul 2025
- Primary completion
- May 2026
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of solifenacin, mirabegron and botulinum toxin type A in overactive bladder (OAB) (4 arms), sponsored by Mackay Medical College. Primary endpoints: Thermodynamic work performed by bladder per voiding cycle and Bladder compliance dynamics. Started Jul 2025; status: recruiting.
02
Drugs
solifenacinmirabegronbotulinum toxin type A
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT07025642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07025642.